HIV-1 Virologic Suppression With TMB-365 and TMB-380 Antibodies Study
HIV-1 Virologic Suppression With TMB-365 and TMB-380 Antibodies Study
Active, not recruiting · NCT07215468 · Registry updated 2026-08-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| HIV-1 Virologic Suppression With TMB-365 and TMB-380 Antibodies Study | HIV -1 Infection | Active, not recruiting | Phase 2 | 2026-08-06 | NCT07215468 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| TaiMed Biologics Inc. | 1 |
10 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| CAN Community Health Fort Lauderdale | Fort Lauderdale | United States | 3 |
| CAN Community Health Las Vegas | Las Vegas | United States | 1 |
| CAN Community Health Miami Gardens | Miami Gardens | United States | 2 |
| CAN Community Health Sarasota | Sarasota | United States | 1 |
| Midland Medical | Oakland Park | United States | 1 |
| Midway Immunology and Research Center (MIRC) | Ft. Pierce | United States | 1 |
| Orlando Immunology Center | Orlando | United States | 11 |
| Quest Clinical Research | San Francisco | United States | 8 |
| The Crofoot Research Center, INC. | Houston | United States | 7 |
| The Rockefeller University | New York | United States | 3 |